Tag Archives: biotechnology law

Views of the EPO Enlarged Appeal Board in Treatment by surgery/MEDI-PHYSICS G 0001/07

Posted on February 18, 2010 by Warren Woessner

Under what circumstances is injection a prohibited surgical method? Views of the EPO Enlarged Appeal Board in Treatment by surgery/MEDI-PHYSICS G 0001/07 .  Opinion From Paul Cole The present proceedings resulted from a referral in decision T 0992/03 relating to EP-A-1066537. … Continue reading →

Posted in Non-U.S. Practice | Tagged , , , , | Leave a comment

PTO Biotech/Chem/Pharma Customer Partnership Meeting Announced

Posted on February 18, 2010 by Warren Woessner

The USPTO has announced that it will hold a meeting of the Biotechnology/Chemical/Pharmaceutical Customer Partnership on Tuesday, March 2nd, in the Madison Auditorium of the USPTO in Alexandria, VA (agenda attached). You can attend in person or via a link … Continue reading →

Posted in USPTO Practice and Policy | Tagged , , , | Leave a comment

ANOTHER “HAIL MARY” CLAIM BITES THE DUST

Posted on February 17, 2010 by Warren Woessner

In my post of April 22, 2009, I spent quite a lot of time discussing why “mechanism of action” claims may issue but, like the “Hail Mary” pass in football, remain vulnerable to invalidation as inherently anticipated by the prior … Continue reading →

Posted in Patenting Methods/Processes | Tagged , , , , | Leave a comment

PTO “POINT SYSTEM” DISTRIBUTED

Posted on February 16, 2010 by Warren Woessner

I thought it worthwhile to post this “point system,” since I had never seen one before. It is encouraging that the highest tier of points an Examiner can achieve is a first office action allowance, but a little discouraging that … Continue reading →

Posted in USPTO Practice and Policy | Tagged , , , , | Leave a comment